CSO and Stroke Association
These summaries of our completed research projects highlight what work was undertaken, which aims were achieved and where the research is going next.
In stroke survivors, does the clinical effectiveness of 6 months treatment with fluoxetine depend upon its effects on synaptic plasticity in the brain? Can a drug used for depression help stroke recovery by changing connections between brain cells?
This study will investigate whether more intensive lowering of blood pressure (BP) in survivors of intracerebral haemorrhage (ICH) is feasible, safe and effective in reducing brain injury.
Published online first in the journal Neurology, a new study investigates the effectiveness of tools used to predict recovery of patients after stroke.
Published in the journal, Lancet Neurology, a new study suggests that understanding stroke severity, as well as time to treatment, is key to delivering effective and safe thrombolysis treatment.
A panel of independent experts has decided that alteplase, a clot-busting drug often used to treat strokes is safe and effective under current guidelines.
A clinical trial to examine if it is effective to use everyday drugs to treat common stroke complications such as fever and infection.
Our Communication Support Service works with stroke survivors and their carers who are living with the effects of communication difficulties, to create opportunities to develop communication strategies, help rebuild confidence and get back to life after stroke.